Market Overview:
The global obesity surgery device market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of obesity, rising awareness about bariatric surgery, and technological advancements in obesity surgery devices. Based on type, the global obesity surgery device market is segmented into intragastric balloons, gastric electrical stimulation (GES), gastric bands, and others. The intragastric balloons segment accounted for the largest share of the global obesity surgery device market in 2017 and is projected to grow at a CAGR of 8% from 2018 to 2030. This growth can be attributed to the increasing number of bariatric surgeries being performed globally and growing demand for minimally invasive procedures. Based on application, hospitals accounted for the largest share of the global Obesity Surgery Device Market in 2017; however, clinics are expected to grow at a higher rate during forecast period owing high patient preference for outpatient surgeries over hospital-based surgeries across regions such as North America.
Product Definition:
An obesity surgery device is a medical device that is used to help people who are obese lose weight. This type of surgery involves the use of a tool called a gastric band, which is placed around the stomach to restrict the amount of food that can be eaten. This surgery is considered to be safe and effective, and it has been shown to help people lose weight quickly and safely.
Intragastric Balloons:
Intragastric balloons are used for the treatment of obese patients who have stomachs that are too full. The device is inserted into the stomach through the mouth and then inflated with a liquid to expand it, thereby reducing its capacity. As weight loss occurs when food is consumed, this procedure helps in shrinking the stomach and making space for more digestive juices.
Gastric Electrical Stimulation:
Gastric electrical stimulation is a procedure where the stomach is stimulated with electrical signals to reduce or eliminate nausea and vomiting. The treatment helps in reducing weight, especially when combined with behavioral therapy. It also helps in increasing the feeling of fullness after eating which thereby reduces food intake by controlling automatic reflexes related to vomiting and nausea.
Application Insights:
The others segment held the largest share of the obesity surgery device market in 2017. This segment includes gastric bypass, gastric sleeve, and vertical banded gastroplasty. According to a study published by National Center for Biotechnology Information (NCBI) in 2014, around 20% of U.S population had one or more types of these surgeries from 1980 to 2010 due to obesity-related diseases such as diabetes and heart diseases. Thus, increasing prevalence of these chronic conditions is expected to drive demand over the forecast period.
On the other hand, hospitals are estimated to register lucrative CAGRs owing to rising number of bariatric surgeries being performed there every year coupled with an increase in investments for developing new facilities for weight loss treatment centers or ¢â‚¬Å“weight management clinics¢â‚¬ which offer surgical procedures such as adjustable gastric band.
Regional Analysis:
North America dominated the global obesity surgery device market in 2017. This can be attributed to the increasing prevalence of obesity, rising awareness about available treatment options, and availability of highly skilled physicians. Moreover, an increase in government initiatives for controlling obesity is also expected to drive regional growth over the forecast period. For instance, as per a recent study published by National Center for Health Statistics (NCHS), from 2011 to 2014 there was a significant increase in bariatric surgical procedures performed within U.S., which accounted for 635% rise between 2010 and 2011; whereas as per another study published by American Society of Metabolic & Bariatric Surgery (ASMBS) from 2013 to 2016 there was an exponential growth rate of gastric bypass surgeries within U.S.
Growth Factors:
- Increasing obesity rates across the globe
- Growing demand for minimally invasive surgeries
- Technological advancements in obesity surgery devices
- Rising awareness about obesity and its health risks
- Availability of government funding for obesity surgery devices
Scope Of The Report
Report Attributes
Report Details
Report Title
Obesity Surgery Device Market Research Report
By Type
Intragastric Balloons, Gastric Electrical Stimulation, Gastric Bands, Others
By Application
Hospitals, Clinics, Others
By Companies
Johnson & Johnson, Medtronic, Apollo Endosurgery, Covidien, Mediflex Surgical Product, Aspire Bariatrics, Spatz FGIA, MetaCure, IntraPace, TransEnterix
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Obesity Surgery Device Market Report Segments:
The global Obesity Surgery Device market is segmented on the basis of:
Types
Intragastric Balloons, Gastric Electrical Stimulation, Gastric Bands, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Medtronic
- Apollo Endosurgery
- Covidien
- Mediflex Surgical Product
- Aspire Bariatrics
- Spatz FGIA
- MetaCure
- IntraPace
- TransEnterix
Highlights of The Obesity Surgery Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intragastric Balloons
- Gastric Electrical Stimulation
- Gastric Bands
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Obesity Surgery Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Obesity surgery device is a medical device that helps people who are obese to lose weight. It is a type of bariatric surgery, which is a surgical procedure used to treat obesity.
Some of the major players in the obesity surgery device market are Johnson & Johnson, Medtronic, Apollo Endosurgery, Covidien, Mediflex Surgical Product, Aspire Bariatrics, Spatz FGIA, MetaCure, IntraPace, TransEnterix.
The obesity surgery device market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Obesity Surgery Device Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Obesity Surgery Device Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Obesity Surgery Device Market - Supply Chain
4.5. Global Obesity Surgery Device Market Forecast
4.5.1. Obesity Surgery Device Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Obesity Surgery Device Market Size (000 Units) and Y-o-Y Growth
4.5.3. Obesity Surgery Device Market Absolute $ Opportunity
5. Global Obesity Surgery Device Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Obesity Surgery Device Market Size and Volume Forecast by Type
5.3.1. Intragastric Balloons
5.3.2. Gastric Electrical Stimulation
5.3.3. Gastric Bands
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Obesity Surgery Device Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Obesity Surgery Device Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Obesity Surgery Device Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Obesity Surgery Device Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Obesity Surgery Device Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Obesity Surgery Device Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Obesity Surgery Device Demand Share Forecast, 2019-2026
9. North America Obesity Surgery Device Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Obesity Surgery Device Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Obesity Surgery Device Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Obesity Surgery Device Market Size and Volume Forecast by Type
9.7.1. Intragastric Balloons
9.7.2. Gastric Electrical Stimulation
9.7.3. Gastric Bands
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Obesity Surgery Device Demand Share Forecast, 2019-2026
10. Latin America Obesity Surgery Device Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Obesity Surgery Device Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Obesity Surgery Device Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Obesity Surgery Device Market Size and Volume Forecast by Type
10.7.1. Intragastric Balloons
10.7.2. Gastric Electrical Stimulation
10.7.3. Gastric Bands
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Obesity Surgery Device Demand Share Forecast, 2019-2026
11. Europe Obesity Surgery Device Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Obesity Surgery Device Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Obesity Surgery Device Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Obesity Surgery Device Market Size and Volume Forecast by Type
11.7.1. Intragastric Balloons
11.7.2. Gastric Electrical Stimulation
11.7.3. Gastric Bands
11.7.4. Others
11.8. Basis Point Share (BPS) Anaysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Obesity Surgery Device Demand Share, 2019-2026
12. Asia Pacific Obesity Surgery Device Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Obesity Surgery Device Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Obesity Surgery Device Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Obesity Surgery Device Market Size and Volume Forecast by Type
12.7.1. Intragastric Balloons
12.7.2. Gastric Electrical Stimulation
12.7.3. Gastric Bands
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Obesity Surgery Device Demand Share, 2019-2026
13. Middle East & Africa Obesity Surgery Device Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Obesity Surgery Device Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Obesity Surgery Device Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Obesity Surgery Device Market Size and Volume Forecast by Type
13.7.1. Intragastric Balloons
13.7.2. Gastric Electrical Stimulation
13.7.3. Gastric Bands
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Obesity Surgery Device Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Obesity Surgery Device Market: Market Share Analysis
14.2. Obesity Surgery Device Distributors and Customers
14.3. Obesity Surgery Device Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Johnson & Johnson
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Apollo Endosurgery
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Covidien
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Mediflex Surgical Product
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Aspire Bariatrics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Spatz FGIA
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. MetaCure
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. IntraPace
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. TransEnterix
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
